Serum cytokine and T regulatory cell levels in patients with burning mouth syndrome

被引:33
|
作者
Pekiner, Filiz Namdar [1 ]
Demirel, Guelderen Yamkkaya [2 ]
Gumru, Birsay [1 ]
Ozbayrak, Semih [1 ]
机构
[1] Marmara Univ, Dept Oral Diag & Radiol, Fac Dent, TR-34365 Istanbul, Turkey
[2] Ctr Labs, Istanbul, Turkey
关键词
burning mouth syndrome; cytokine; serum; T regulatory cell;
D O I
10.1111/j.1600-0714.2008.00668.x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
BACKGROUND: Burning mouth syndrome is a disorder usually associated with an unexplained, prolonged sensation of burning inside the oral cavity. Although the etiology is unknown, neural and psychologic factors and cytokines may be implicated in the pathogenesis of burning mouth syndrome. The aim of this study was to investigate the relationship between serum cytokine and T regulatory cell levels in patients with burning mouth syndrome with regard to depression and anxiety. METHODS: Thirty patients with burning mouth syndrome and 30 matched controls participated in the study. Serum cytokine levels were measured with cytometric bead array and T regulatory cells were defined as CD4(+)CD25(+)Foxp-3(+) cells by flow cytometry. The level of anxiety and depression were analyzed by means of the Speilberger State-Trait Anxiety Inventory and Zung Self-Rating Depression Scale. Visual analogue scale was used in the quantification of burning levels of patients. RESULTS: Serum IL-2 and TNF-alpha levels were significantly decreased in patients with burning mouth syndrome compared with controls [mean 16.79 +/- 8.70 vs. 37.73 +/- 41.05 pg/ml (P < 0.05) and mean 39.09 +/- 29.40 vs. 70.83 +/- 42.44 pg/ml (P < 0.01) respectively]. CONCLUSIONS: IL-2 and TNF-alpha might play a role in burning mouth syndrome. Burning mouth syndrome may occur as a sign of predisposition to autoimmunity. Presence of low levels of CD28(+) supports the provision that BMS might be a pre-otoimmune disease.
引用
收藏
页码:528 / 534
页数:7
相关论文
共 50 条
  • [31] The correlation of regulatory miRNAs with cytokine serum levels and cytokine genes' polymorphisms
    Surowiecka-Pastewka, A.
    Zagozda, M.
    Zakoscielna, E.
    Durlik, M.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S29 - S29
  • [32] Serum interleukin-6 in patients with burning mouth syndrome and relationship with depression and perceived pain
    Chen, Qianming
    Xia, Juan
    Lin, Mei
    Zhou, Hongmei
    Li, Bingqi
    MEDIATORS OF INFLAMMATION, 2007, 2007
  • [33] The Clinical Analysis of 47 Patients with Burning Mouth Syndrome
    WANG YuzhongXIE HaoSchool of Stomatology Wuhan UniversityWuhan
    口腔医学纵横, 2002, (01) : 47 - 48
  • [34] Treatment with amitriptyline of three patients with burning mouth syndrome
    Tas, Halil Ibrahim
    Ustundag, Mehmet Fatih
    Ozcan, Halil
    ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY, 2015, 16 (05): : 379 - 379
  • [35] Burning mouth syndrome in patients with different metal alloys
    Muhvic-Urek, M.
    Glazar, I.
    Jurcevic, M.
    Prpic, J.
    Borcic, J.
    Pezelj-Ribaric, S.
    ORAL DISEASES, 2012, 18 : 17 - 17
  • [36] A systematic review of treatment for patients with burning mouth syndrome
    Tan, Huann Lan
    Smith, Jared G.
    Hoffmann, Jan
    Renton, Tara
    CEPHALALGIA, 2022, 42 (02) : 128 - 161
  • [37] Assessment of effectiveness of clonazepam in patients with burning mouth syndrome
    Mendizabal, M.
    Lana, J.
    Ginestal, E.
    CEPHALALGIA, 2015, 35 : 109 - 109
  • [38] Perception of stimulus size in patients with burning mouth syndrome
    Lamey, PJ
    Hobson, RS
    Orchardson, R
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 1996, 25 (08) : 420 - 423
  • [39] Characterization of a population (312 patients) with burning mouth syndrome
    Henriques, I.
    Cardoso, I.
    Pinto, A. C.
    Trancoso, P.
    Azul, A.
    ORAL DISEASES, 2016, 22 : 27 - 28
  • [40] Evaluation of tumour markers in patients with burning mouth syndrome
    Vucicevic-Boras, V
    Lukinac, LJ
    Cekic-Arambasin, A
    ORAL ONCOLOGY, 2003, 39 (07) : 742 - 744